1.Expressions of N HERF1 and β-catenin in primary extramammary Paget's disease tissue and their significance
Ziyu DUAN ; Wei ZHANG ; Amei LI ; Yalin Lü ; Hao CHEN ; Xuesi ZENG ; Jianfang SUN
Chinese Journal of Dermatology 2013;46(8):561-564
Objective To investigate the expressions of Na+/H+ exchanger regulatory factor 1 (NHERF1) and β-catenin in extramammary Paget's disease tissue as well as their significance.Methods Immunohistochemistry was performed to detect the protein expressions of NHERF1 and β-catenin in paraffin-embeded tissue samples from 18 patients with in situ and 22 patients with invasive extramammary Paget's disease.Results There was a high expression of NHERF1 protein in 18 (81.82%) invasive and 7 (38.89%) in situ extramammary Paget's disease samples (x2 =7.78,P < 0.01).Statistical differences were observed in the membrane expression rate and cytoplasmic or nuclear expression rate of β-catenin between invasive and in situ extramammary Paget's disease tissue samples (0 (0/22) vs.33.33% (6/18),x2 =8.63,P < 0.01; 81.82% (18/22) vs.44.44% (8/18),x2 =6.08,P < 0.05).In extramammary Paget's disease in situ tissue samples,the expression of NHERF1 was negatively correlated with the cytomembrane expression of β-catenin (ρ =-0.488,P < 0.01),but positively correlated with the cytoplasmic or nuclear expression of β-catenin (ρ =0.623,P < 0.01),and there was a negative correlation between the cytomembrane and cytoplasmic or nuclear expression of β-catenin (ρ =-0.572,P < 0.01).Conclusions There is an abnormal expression of NHERF1 and β-catenin in extramammary Paget's disease tissue,which may be associated with the initiation,progression,and invasion of primary extramammary Paget's disease.
2.Enlightment of routine vaccination under the prevention and control of COVID-19 based on the circulating event of type Ⅲ vaccine-derived poliovirus in Shanghai.
Xiang GUO ; Zhi LI ; JianPing YANG ; JiaYu HU ; ZhuoYing HUANG ; Jing QIU ; XiaoYing MA ; JianFang DUAN ; XiaoDong SUN
Chinese Journal of Preventive Medicine 2021;55(12):1377-1382
Since the Global Polio Eradication Initiative was launched by the World Health Assembly in 1988, significant progress has been made in global polio prevention and control. But the occurrence of vaccine-associated paralytic poliomyelitis cases and vaccine-derived poliovirus related cases have become a major challenge during the post-polio era. While coronavirus disease 2019(COVID-19) has brought serious disease burden and economic burden to all countries in the world, prevention and control of vaccine-preventable infectious diseases such as polio should not be neglected under the background of the global common fight against COVID-19. Taking the type Ⅲ VDPV cycle event in Shanghai as an example, the paper discussed how to do a good job of routine inoculation under the prevention and control of COVID-19 to strictly prevent the outbreak of vaccine-preventable infectious diseases.
COVID-19
;
China
;
Humans
;
Poliovirus
;
Poliovirus Vaccine, Oral
;
SARS-CoV-2
;
Vaccination